Literature DB >> 32632291

Inefficient CAR-proximal signaling blunts antigen sensitivity.

Venugopal Gudipati1, Julian Rydzek2, Iago Doel-Perez1, Vasco Dos Reis Gonçalves2, Lydia Scharf1,3, Sebastian Königsberger1,4, Elisabeth Lobner5, Renate Kunert5, Hermann Einsele2, Hannes Stockinger1, Michael Hudecek6, Johannes B Huppa7.   

Abstract

Rational design of chimeric antigen receptors (CARs) with optimized anticancer performance mandates detailed knowledge of how CARs engage tumor antigens and how antigen engagement triggers activation. We analyzed CAR-mediated antigen recognition via quantitative, single-molecule, live-cell imaging and found the sensitivity of CAR T cells toward antigen approximately 1,000-times reduced as compared to T cell antigen-receptor-mediated recognition of nominal peptide-major histocompatibility complexes. While CARs outperformed T cell antigen receptors with regard to antigen binding within the immunological synapse, proximal signaling was significantly attenuated due to inefficient recruitment of the tyrosine-protein kinase ZAP-70 to ligated CARs and its reduced concomitant activation and subsequent release. Our study exposes signaling deficiencies of state-of-the-art CAR designs, which presently limit the efficacy of CAR T cell therapies to target tumors with diminished antigen expression.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32632291     DOI: 10.1038/s41590-020-0719-0

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  51 in total

1.  Direct observation of ligand recognition by T cells.

Authors:  Darrell J Irvine; Marco A Purbhoo; Michelle Krogsgaard; Mark M Davis
Journal:  Nature       Date:  2002-10-24       Impact factor: 49.962

2.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

3.  Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Authors:  John Maher; Renier J Brentjens; Gertrude Gunset; Isabelle Rivière; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

4.  A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells.

Authors:  Jun Huang; Mario Brameshuber; Xun Zeng; Jianming Xie; Qi-jing Li; Yueh-hsiu Chien; Salvatore Valitutti; Mark M Davis
Journal:  Immunity       Date:  2013-10-10       Impact factor: 31.745

5.  Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.

Authors:  H M Finney; A D Lawson; C R Bebbington; A N Weir
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

6.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

7.  CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

Authors:  Cameron J Turtle; Laïla-Aïcha Hanafi; Carolina Berger; Theodore A Gooley; Sindhu Cherian; Michael Hudecek; Daniel Sommermeyer; Katherine Melville; Barbara Pender; Tanya M Budiarto; Emily Robinson; Natalia N Steevens; Colette Chaney; Lorinda Soma; Xueyan Chen; Cecilia Yeung; Brent Wood; Daniel Li; Jianhong Cao; Shelly Heimfeld; Michael C Jensen; Stanley R Riddell; David G Maloney
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 8.  Engineering CAR-T cells: Design concepts.

Authors:  Shivani Srivastava; Stanley R Riddell
Journal:  Trends Immunol       Date:  2015-07-11       Impact factor: 16.687

9.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

10.  Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.

Authors:  C Imai; K Mihara; M Andreansky; I C Nicholson; C-H Pui; T L Geiger; D Campana
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

View more
  26 in total

1.  Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.

Authors:  Nam Gyu Im; Amy Guillaumet-Adkins; Jens G Lohr; Birgit Knoechel; Megha Wal; Anna J Rogers; Julia Frede; Claire C Havig; Jing Yang; Praveen Anand; Sarah K Stegmann; Johannes M Waldschmidt; Noori Sotudeh; Leili Niu; Jordan Voisine; Michal R Schweiger; Clemens Grassberger
Journal:  Cancer Immunol Res       Date:  2022-09-01       Impact factor: 12.020

2.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

3.  High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Authors:  Carmen Alvarez-Fernández; Javier Briones; Ana Carolina Caballero; Laura Escribà-Garcia; Paula Pujol-Fernández; Eva Escudero-López; Cristina Ujaldón-Miró; Rosanna Montserrat-Torres; Jorge Sierra
Journal:  Cancer Gene Ther       Date:  2022-08-29       Impact factor: 5.854

4.  Negative Regulation of Zap70 by Lck Forms the Mechanistic Basis of Differential Expression in CD4 and CD8 T Cells.

Authors:  Hassan Damen; Christian Tebid; Melissa Viens; Denis-Claude Roy; Vibhuti P Dave
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 5.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

6.  GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.

Authors:  Sabine Heitzeneder; Kristopher R Bosse; Zhongyu Zhu; Doncho Zhelev; Robbie G Majzner; Molly T Radosevich; Shaurya Dhingra; Elena Sotillo; Samantha Buongervino; Guillem Pascual-Pasto; Emily Garrigan; Peng Xu; Jing Huang; Benjamin Salzer; Alberto Delaidelli; Swetha Raman; Hong Cui; Benjamin Martinez; Scott J Bornheimer; Bita Sahaf; Anya Alag; Irfete S Fetahu; Martin Hasselblatt; Kevin R Parker; Hima Anbunathan; Jennifer Hwang; Min Huang; Kathleen Sakamoto; Norman J Lacayo; Dorota D Klysz; Johanna Theruvath; José G Vilches-Moure; Ansuman T Satpathy; Howard Y Chang; Manfred Lehner; Sabine Taschner-Mandl; Jean-Phillipe Julien; Poul H Sorensen; Dimiter S Dimitrov; John M Maris; Crystal L Mackall
Journal:  Cancer Cell       Date:  2021-12-30       Impact factor: 38.585

7.  Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.

Authors:  Laura Evgin; Tim Kottke; Jason Tonne; Jill Thompson; Amanda L Huff; Jacob van Vloten; Madelyn Moore; Josefine Michael; Christopher Driscoll; Jose Pulido; Eric Swanson; Richard Kennedy; Matt Coffey; Houra Loghmani; Luis Sanchez-Perez; Gloria Olivier; Kevin Harrington; Hardev Pandha; Alan Melcher; Rosa Maria Diaz; Richard G Vile
Journal:  Sci Transl Med       Date:  2022-04-13       Impact factor: 19.319

8.  Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.

Authors:  Yuedi Wang; Yiyuan Gao; Congyi Niu; Bo Wang; Shushu Zhao; Gils Roex; Jiawen Qian; Jingbo Qie; Lin Chen; Chenhe Yi; Sébastien Anguille; Jie Liu; Feifei Luo; Yiwei Chu
Journal:  Cancer Immunol Immunother       Date:  2022-04-19       Impact factor: 6.630

9.  The discriminatory power of the T cell receptor.

Authors:  Johannes Pettmann; Anna Huhn; Enas Abu Shah; Mikhail A Kutuzov; Daniel B Wilson; Michael L Dustin; Simon J Davis; P Anton van der Merwe; Omer Dushek
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

10.  Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function.

Authors:  Alexander I Salter; Anusha Rajan; Jacob J Kennedy; Richard G Ivey; Sarah A Shelby; Isabel Leung; Megan L Templeton; Vishaka Muhunthan; Valentin Voillet; Daniel Sommermeyer; Jeffrey R Whiteaker; Raphael Gottardo; Sarah L Veatch; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2021-08-24       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.